PL369227A1 - Odmiany polimorficzne pochodnej 1-pirolu, półproduktu do otrzymywania atorvastatinu - Google Patents
Odmiany polimorficzne pochodnej 1-pirolu, półproduktu do otrzymywania atorvastatinuInfo
- Publication number
- PL369227A1 PL369227A1 PL02369227A PL36922702A PL369227A1 PL 369227 A1 PL369227 A1 PL 369227A1 PL 02369227 A PL02369227 A PL 02369227A PL 36922702 A PL36922702 A PL 36922702A PL 369227 A1 PL369227 A1 PL 369227A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- phenyl
- atorvastatin
- polymorphs
- ethyl
- Prior art date
Links
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 title abstract 2
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 title abstract 2
- 229960005370 atorvastatin Drugs 0.000 title abstract 2
- 239000005515 coenzyme Substances 0.000 abstract 1
- 229940125532 enzyme inhibitor Drugs 0.000 abstract 1
- 239000002532 enzyme inhibitor Substances 0.000 abstract 1
- -1 hydroxymethyl-glutaryl Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000012450 pharmaceutical intermediate Substances 0.000 abstract 1
- NPPZOMYSGNZDKY-ROJLCIKYSA-N tert-butyl 2-[(4r,6r)-6-[2-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@H]2OC(C)(C)O[C@@H](CC(=O)OC(C)(C)C)C2)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 NPPZOMYSGNZDKY-ROJLCIKYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0103702A HU227124B1 (en) | 2001-09-14 | 2001-09-14 | Polymorphs of 1-pyrrole derivative, intermediate for the preparation of atorvastatin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL369227A1 true PL369227A1 (pl) | 2005-04-18 |
| PL217253B1 PL217253B1 (pl) | 2014-06-30 |
Family
ID=89979680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL369227A PL217253B1 (pl) | 2001-09-14 | 2002-09-13 | Odmiany polimorficzne pochodnej 1-pirolu oraz sposób ich otrzymywania |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7186848B2 (pl) |
| EP (1) | EP1430049B1 (pl) |
| JP (1) | JP2005505572A (pl) |
| KR (1) | KR20040029482A (pl) |
| AT (1) | ATE394393T1 (pl) |
| CY (1) | CY1108235T1 (pl) |
| CZ (1) | CZ2004469A3 (pl) |
| DE (1) | DE60226463D1 (pl) |
| DK (1) | DK1430049T3 (pl) |
| EA (1) | EA007104B1 (pl) |
| ES (1) | ES2306778T3 (pl) |
| HU (1) | HU227124B1 (pl) |
| PL (1) | PL217253B1 (pl) |
| PT (1) | PT1430049E (pl) |
| SK (1) | SK1722004A3 (pl) |
| UA (1) | UA76496C2 (pl) |
| WO (1) | WO2003024959A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050119270A1 (en) * | 2000-08-04 | 2005-06-02 | Mason R. P. | Synergistic effect of amlodipine and atorvastatin on aortic endothelial cell nitric oxide release |
| EP1711489B1 (en) * | 2003-12-29 | 2012-12-26 | LEK Pharmaceuticals d.d. | Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| WO2006032959A2 (en) * | 2004-08-06 | 2006-03-30 | Glenmark Pharmaceuticals Limited | Processes for the preparation of pyrrole derivatives |
| KR101255204B1 (ko) * | 2012-07-23 | 2013-04-23 | 주식회사 베프스 | 보안 기능을 갖는 저장 장치 리더기 및 이를 이용한 보안 방법 |
| CN106938996B (zh) * | 2016-01-05 | 2019-11-19 | 天方药业有限公司 | 一种阿托伐他汀钙中间体的制备方法 |
| CN111362856B (zh) * | 2020-04-29 | 2023-08-18 | 福建海西新药创制股份有限公司 | 一种利用微反应装置生产阿托伐他汀钙的方法 |
| WO2026006786A1 (en) * | 2024-06-28 | 2026-01-02 | Osanni Bio, Inc. | Compound, compositions, and methods of use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5003080A (en) * | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
| US5103024A (en) * | 1990-10-17 | 1992-04-07 | Warner-Lambert Company | Process for the synthesis of (4r-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
| US5217453A (en) * | 1991-03-18 | 1993-06-08 | Wilk Peter J | Automated surgical system and apparatus |
| EP0688536B1 (de) * | 1994-03-23 | 2000-08-02 | Erbe Elektromedizin GmbH | Multifunktionales Instrument für die Ultraschall-Chirurgie |
| US5526822A (en) * | 1994-03-24 | 1996-06-18 | Biopsys Medical, Inc. | Method and apparatus for automated biopsy and collection of soft tissue |
| GEP20002029B (en) * | 1995-07-17 | 2000-04-10 | Warner Lambert Company Us | (54) Crystalline [R-(R*,R*,]–2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methyl-Ethyl)-3-Phenyl–4-{Phenylamino) Carbonyl} - 1H - Pyrrole - 1 - Heptanoic Acid Hemi Calcium Salt (Atorvastatin) |
| US5871495A (en) * | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
| SI20814A (sl) * | 2001-01-23 | 2002-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Priprava amorfnega atorvastatina |
-
2001
- 2001-09-14 HU HU0103702A patent/HU227124B1/hu not_active IP Right Cessation
-
2002
- 2002-09-13 US US10/489,686 patent/US7186848B2/en not_active Expired - Fee Related
- 2002-09-13 EA EA200400391A patent/EA007104B1/ru not_active IP Right Cessation
- 2002-09-13 PT PT02758667T patent/PT1430049E/pt unknown
- 2002-09-13 SK SK172-2004A patent/SK1722004A3/sk unknown
- 2002-09-13 JP JP2003528806A patent/JP2005505572A/ja active Pending
- 2002-09-13 KR KR10-2004-7003753A patent/KR20040029482A/ko not_active Ceased
- 2002-09-13 AT AT02758667T patent/ATE394393T1/de active
- 2002-09-13 EP EP02758667A patent/EP1430049B1/en not_active Expired - Lifetime
- 2002-09-13 ES ES02758667T patent/ES2306778T3/es not_active Expired - Lifetime
- 2002-09-13 WO PCT/HU2002/000088 patent/WO2003024959A1/en not_active Ceased
- 2002-09-13 DE DE60226463T patent/DE60226463D1/de not_active Expired - Lifetime
- 2002-09-13 DK DK02758667T patent/DK1430049T3/da active
- 2002-09-13 PL PL369227A patent/PL217253B1/pl unknown
- 2002-09-13 UA UA20040402706A patent/UA76496C2/uk unknown
- 2002-09-13 CZ CZ2004469A patent/CZ2004469A3/cs unknown
-
2008
- 2008-07-31 CY CY20081100812T patent/CY1108235T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK1722004A3 (en) | 2004-08-03 |
| HU0103702D0 (en) | 2001-11-28 |
| PL217253B1 (pl) | 2014-06-30 |
| ES2306778T3 (es) | 2008-11-16 |
| ATE394393T1 (de) | 2008-05-15 |
| UA76496C2 (uk) | 2006-08-15 |
| EP1430049A1 (en) | 2004-06-23 |
| EP1430049B1 (en) | 2008-05-07 |
| US20040249168A1 (en) | 2004-12-09 |
| EA007104B1 (ru) | 2006-06-30 |
| DK1430049T3 (da) | 2008-09-01 |
| HUP0103702A3 (en) | 2007-08-28 |
| HUP0103702A2 (hu) | 2003-06-28 |
| DE60226463D1 (de) | 2008-06-19 |
| CY1108235T1 (el) | 2014-02-12 |
| WO2003024959A1 (en) | 2003-03-27 |
| JP2005505572A (ja) | 2005-02-24 |
| EA200400391A1 (ru) | 2005-02-24 |
| HU227124B1 (en) | 2010-07-28 |
| KR20040029482A (ko) | 2004-04-06 |
| PT1430049E (pt) | 2008-08-08 |
| US7186848B2 (en) | 2007-03-06 |
| CZ2004469A3 (cs) | 2004-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005014539A3 (en) | Pyrrole-based hmg-coa reductase inhibitors | |
| EE05531B1 (et) | Tert-butl-(E)-(6-{2-[4-(4-fluorofenl)-6-isopropl-2-[metl(metlsulfonl)amino]primidiin-5-l]vinl}(4R, 6S)-2,2-dimetl[1,3]dioksaan-4-l)atsetaadi valmistamismeetod | |
| RU2003125647A (ru) | Способ синтеза авторвастатина и промежуточный фенилборонат (вараинты) | |
| CY1108235T1 (el) | Πολυμορφα ενος παραγωγου 1-πυρρολιου ενδιαμεσου για τη παρασκευη ατορβαστατινης | |
| IL167434A (en) | N-(substituted glycyl)-2,5-disubstituted pyrrolidines for use as inhibitors of dipeptidyl peptidase-iv (dpp-iv) and pharmaceutical compositions comprising the same | |
| AU3368400A (en) | Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammationassociated with pulmonary disease | |
| YU56803A (sh) | Pripremanje nekristalinskog atorvastatin-kalcijuma | |
| WO2002010154A3 (en) | Substituted heterocyclic amides | |
| NO20032200D0 (no) | Hydrolyse av [R(R*,R*)]-2-(4-fluorfenyl)-<beta>,<delta>- dihydroksy-5-(1-metyletyl)-3-fenyl-4-[(fenylamino)karbonyl]-1H-pyrrol-1-heptansyreestere med kalsiumhydroksid | |
| WO2004096128A3 (en) | Hiv integrase inhibitors | |
| ES2194202T3 (es) | Compuestos polimorfos. | |
| AU2003245313A1 (en) | Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives (statins), novel combinations thereof as well as manufacturing of these pharmaceutical compositions | |
| AU2003250172A1 (en) | Compositions comprising hmg-coa reductase inhibitor | |
| EP2319843B1 (en) | Substituted pyrrole derivatives and their use as HMG-CO inhibitors | |
| PE20061057A1 (es) | DERIVADOS DE PIRAZOL COMO INHIBIDORES DE HMG CoA REDUCTASA | |
| AU4543699A (en) | Multibinding inhibitors of hmg-coa reductase | |
| HRP20040888B1 (en) | Novel boronate esters | |
| BRPI0417138A (pt) | n-alquil-pirroles como inibidores de hmg-coa-redutase | |
| PT1102765E (pt) | Processo para a sintese de derivados de (1h)-benzo¬c|quinolizin-3-onas | |
| TW200724688A (en) | Process for producing atorvastatin, pharmaceutically acceptable salts thereof and intermediates thereof | |
| WO2009023260A3 (en) | An improved process for synthesis of pyrrole derivative, an intermediate for atorvastatin | |
| ATE496025T1 (de) | Magnesiumsalze von hmg-coa-reduktase-hemmern | |
| PL367885A1 (pl) | Analogi metylowe symwastatyny jako nowe inhibitory reduktazy HMG-CoA | |
| WO2006134613A3 (en) | Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors | |
| WO2005023826A3 (en) | Polymorphic nucleoside compounds |